BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20334135)

  • 1. Design, synthesis and biological evaluation of novel spin-labeled derivatives of podophyllotoxin.
    Zhang JQ; Zhang ZW; Hui L; Tian X
    Nat Prod Commun; 2010 Feb; 5(2):241-4. PubMed ID: 20334135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of new spin-labeled derivatives of podophyllotoxin.
    Jin Y; Chen SW; Tian X
    Bioorg Med Chem; 2006 May; 14(9):3062-8. PubMed ID: 16406792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel semisynthetic spin-labeled derivatives of podophyllotoxin with cytotoxic and antioxidative activity.
    Zhang JQ; Zhang ZW; Hui L; Chen SW; Tian X
    Bioorg Med Chem Lett; 2010 Feb; 20(3):983-6. PubMed ID: 20053564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and cytotoxic activity of novel derivatives of 4'-demethylepipodophyllotoxin.
    Chen SW; Tian X; Tu YQ
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5063-6. PubMed ID: 15380199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of novel spin-labeled derivatives of podophyllotoxin as potential antineoplastic agents. Part XII.
    Yang L; Liu YQ; Tan H; Li WG; Tian X
    Nat Prod Res; 2007 Sep; 21(11):998-1008. PubMed ID: 17691049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents.
    Reddy PB; Agrawal SK; Singh S; Bhat BA; Saxena AK; Kumar HM; Qazi GN
    Chem Biodivers; 2008 Sep; 5(9):1792-802. PubMed ID: 18816530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel conjugates of podophyllotoxin and 5-FU as antineoplastic agents.
    Chen SW; Xiang R; Liu J; Tian X
    Bioorg Med Chem; 2009 Apr; 17(8):3111-7. PubMed ID: 19324555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor agents. 234. Design, synthesis, and biological evaluation of novel 4beta-[(4' '-benzamido)-amino]-4'-o-demethyl-epipodophyllotoxin derivatives.
    Xiao Z; Bastow KF; Vance JR; Sidwell RS; Wang HK; Chen MS; Shi Q; Lee KH
    J Med Chem; 2004 Oct; 47(21):5140-8. PubMed ID: 15456257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
    Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
    Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First synthesis and biological evaluation of novel spin-labeled derivatives of deoxypodophyllotoxin.
    Zhang ZW; Zhang JQ; Hui L; Chen SW; Tian X
    Eur J Med Chem; 2010 Apr; 45(4):1673-7. PubMed ID: 20071056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.
    Zhang ZH; Zhang LM; Luo G; Zhang S; Chen H; Zhou J
    J Asian Nat Prod Res; 2014; 16(5):527-34. PubMed ID: 24824554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on novel 4beta-[(4-substituted)-1,2,3-triazol-1-yl] podophyllotoxins as potential anticancer agents.
    Bhat BA; Reddy PB; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
    Eur J Med Chem; 2008 Oct; 43(10):2067-72. PubMed ID: 17988764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: design, synthesis and biological evaluation.
    Reddy DM; Srinivas J; Chashoo G; Saxena AK; Sampath Kumar HM
    Eur J Med Chem; 2011 Jun; 46(6):1983-91. PubMed ID: 21477899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological study of a new series of 4'-demethylepipodophyllotoxin derivatives.
    Duca M; Guianvarc'h D; Meresse P; Bertounesque E; Dauzonne D; Kraus-Berthier L; Thirot S; Léonce S; Pierré A; Pfeiffer B; Renard P; Arimondo PB; Monneret C
    J Med Chem; 2005 Jan; 48(2):593-603. PubMed ID: 15658872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles.
    Zhu XK; Guan J; Tachibana Y; Bastow KF; Cho SJ; Cheng HH; Cheng YC; Gurwith M; Lee KH
    J Med Chem; 1999 Jul; 42(13):2441-6. PubMed ID: 10395485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and cytotoxic activity on human cancer cells of carbamate derivatives of 4β-(1,2,3-triazol-1-yl)podophyllotoxin.
    Liu JF; Sang CY; Xu XH; Zhang LL; Yang X; Hui L; Zhang JB; Chen SW
    Eur J Med Chem; 2013 Jun; 64():621-8. PubMed ID: 23711769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of novel 4β-(1,3,4-oxadiazole-2-amino)-podophyllotoxin derivatives.
    Ren J; Wu L; Xin WQ; Chen X; Hu K
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4778-82. PubMed ID: 22687745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of 4β-acrylamidopodophyllotoxin congeners as DNA damaging agents.
    Kamal A; Suresh P; Janaki Ramaiah M; Mallareddy A; Kumar BA; Raju P; Vinay Gopal J; Pushpavalli SN; Lavanya A; Sarma P; Pal-Bhadra M
    Bioorg Med Chem; 2011 Aug; 19(15):4589-600. PubMed ID: 21737288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of sulfonamide derivatives of epipodophyllotoxin.
    Guianvarc'h D; Duca M; Boukarim C; Kraus-Berthier L; Léonce S; Pierré A; Pfeiffer B; Renard P; Arimondo PB; Monneret C; Dauzonne D
    J Med Chem; 2004 Apr; 47(9):2365-74. PubMed ID: 15084135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 4β-triazole-podophyllotoxin derivatives by azide-alkyne cycloaddition and biological evaluation as potential antitumor agents.
    Chen H; Zuo S; Wang X; Tang X; Zhao M; Lu Y; Chen L; Liu J; Liu Y; Liu D; Zhang S; Li T
    Eur J Med Chem; 2011 Sep; 46(9):4709-14. PubMed ID: 21821321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.